Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody

Upregulation of Toll-like receptor 2 (TLR2) plays a critical role in inflammation associated with ischemia/reperfusion–induced tissue damage. OPN-305 is the first humanized IgG4 monoclonal antibody against TLR2 in development and is intended for the prevention of reperfusion injury following renal t...

Descripción completa

Detalles Bibliográficos
Autores principales: Reilly, M, Miller, R M, Thomson, M H, Patris, V, Ryle, P, McLoughlin, L, Mutch, P, Gilboy, P, Miller, C, Broekema, M, Keogh, B, McCormack, W, van de Wetering de Rooij, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805945/
https://www.ncbi.nlm.nih.gov/pubmed/23880971
http://dx.doi.org/10.1038/clpt.2013.150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805945/
https://www.ncbi.nlm.nih.gov/pubmed/23880971
http://dx.doi.org/10.1038/clpt.2013.150

Ejemplares similares